Navigation Links
Fox Chase finds all-biologic regimen efficacious and well-tolerated in elderly lung cancer patients
Date:8/1/2009

SAN FRANCISCO (August 1, 2009)Previously untreated non-small cell lung cancer (NSCLC) patients over the age of 70 respond well to a combination of bevacizumab and erlotinib, Fox Chase Cancer Center researchers reported today at the annual meeting of the International Association for the Study of Lung Cancer.

"Based on our initial data, the combination appears to be well tolerated and efficacious, though we'll have to wait and see the final results," says Hossein Borghaei, D.O., medical oncologist at Fox Chase, who led the trial.

Elderly patients are often excluded from clinical trials because researchers fear they will have trouble tolerating standard chemotherapy regimens. That leaves open the question of how best to treat these individuals who account for more than half of all NSCLC in the United States.

With that challenge in mind, Borghaei and colleagues designed a trial testing a combination of two molecularly targeted agents in patients 70 years or older. The team reasoned that a combination lacking standard cytotoxic agents may be better tolerated by these patients, potentially without comprising efficacy. "We looked for a regimen that had few side effects, would involve only targeted agents, and had a bit of a track record. This combination was a natural fit," Borghaei says. Several small phase II trials in younger NSCLC patients demonstrated that the combination had anti-tumor activity and a relatively favorable toxicity profile.

Thus far 21 elderly NSCLC patients have enrolled in the Fox Chase trial and 14 are evaluable for response. The median age of the 14 evaluable patients is 78, with a range of 71 to 84 years. Four patients have had partial responses with demonstrable tumor shrinkage and three patients had stable disease by RECIST criteria.

The combination appears safe and well tolerated in this patient population with the most commonly encountered toxicities of clinical relevance being high blood pre
'/>"/>

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
2. Northstar Healthcare Announces Option to Purchase a 60% Interest in The Palladium for Surgery - Dallas
3. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
4. Consumer Group: Hillary Clintons Mandatory Health Insurance Purchase Plan is an Act of War on the Middle Class Family That Cant Afford $12k Policy
5. Kensey Nash Announces $25 Million Stock Repurchase Program
6. Nunez and Legislators Urged to Oppose Mandatory Purchase of Private Health Insurance
7. Flextronics Announces Redemption and Change of Control Repurchase Offer for Solectron 8.00% Senior Subordinated Notes and Planned Change of Control Repurchase Offer for Solectrons 0.50% Senior Convertible Notes
8. First Nationwide Class Action Filed on Behalf of Consumers Who Purchased Topps E. Coli Contaminated Ground Beef
9. Hospital Corporation of America Purchases Seventh CyberKnife(R) System
10. Dixtal Medical Purchases Novametrix Pulse Oximetry Business from Respironics
11. Governor Schwarzeneggers Mandatory Purchase of Private Health Insurance Doesnt Add Up for the Middle-Class, Says FTCR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 WellCare Health Plans, Inc. (NYSE: WCG) ... by the Florida Healthy Kids Corporation (FHKC) to continue to ... as part of the Florida Healthy Kids (FHK) program. Pending ... and may be extended for two additional years at FHKC’s ... in the FHK program who live in Regions 1, 2, ...
(Date:5/21/2015)... May 21, 2015 Ticket Down is a reliable ... USA vs. Guatemala on Friday, July 3rd at LP ... to become a fan of international soccer. The number of chances ... on American soil is growing at a large clip. Over the ... come to the USA to play in front of the American ...
(Date:5/21/2015)... Bird B Gone, the leader in bird ... new sizes of the Bird Spike 2001 to its comprehensive ... bird spike is specifically designed to reduce building maintenance ... lines, parapet walls, I-beams, window ledges and more. It is ... boxes, allowing customers to buy the right amount of spike ...
(Date:5/21/2015)... Amercanex today announced that it is ... electronic marketplace for industrial hemp and associated products. ... which wholesale and retail distributors of hemp can ... a fully disclosed and transparent environment. , Amerhempex ... unique blend of cutting-edge infrastructure, tools, and needs-based ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Shimadzu ... AOC-6000 robotic autosampler, which features new time-saving tools ... standard injection techniques: liquid, headspace, and solid-phase microextraction ... This new tool allows users to seamlessly change ... the GC/MS. , The new autosampler allows for ...
Breaking Medicine News(10 mins):Health News:WellCare Selected to Continue Participating in the Florida Healthy Kids Program, Will Serve Nine Florida Regions Under the New Contract 2Health News:USA vs. Guatemala Tickets: Ticket Down Slashes United States Men's Soccer Team (USMNT) vs. Guatemala Tickets at LP Field in Nashville on 7/3/15 2Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 2Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 3Health News:Amercanex is Revolutionizing Order and Efficiency in the Hemp Industry 2Health News:Shimadzu’s New AOC-6000 Autosampler Makes Automated Sample Introduction Simple and Efficient 2
... for Parkinson,s Research announced awards totaling approximately $10.1 million ... development projects. The funding includes $2.5 million to drive ... one of the Foundation,s Edmond J. Safra Core Programs ... Clinical Intervention Awards are: , Charlotte Keywood, Addex ...
... HealthDay Reporter , TUESDAY, Oct. 5 (HealthDay News) ... who received ,hands-only, cardiopulmonary resuscitation (CPR) from a bystander ... who received no CPR or conventional CPR with mouth-to-mouth ... not only is ,hands-only, CPR -- in which the ...
... Saint Louis University researcher, scientists have identified an important microRNA ... blood. Led by ngel Baldn, Ph.D., assistant professor ... published in a recent issue of Proceedings of the ... America, the study found that the microRNA miR-33, may ...
... The National Institutes of Health has awarded a ... Florida and Tampa-based biotechnology company Saneron-CCEL Therapeutics, Inc., ... human umbilical cord blood cells (HUBC) into animal ... use the pre-clinical data to gain U.S. Food ...
... Oct. 5, 2010 Only about a third of ... recommendations, which means they are likely missing out ... Along with vitamins, minerals and fiber, fruits and vegetables ... suggests help support women,s health including breast and ovarian ...
... 2010 Elsevier, the leading publisher of scientific, ... announced a new version of its online research ... was well received by the neuroscience researcher community ... In the updated version, BrainNavigator 3.0, Elsevier has ...
Cached Medicine News:Health News:MJFF announces over $10 million in funding for clinical and pre-clinical PD research 2Health News:'Hands-Only' CPR May Work Best for Cardiac Arrest 2Health News:'Hands-Only' CPR May Work Best for Cardiac Arrest 3Health News:'Hands-Only' CPR May Work Best for Cardiac Arrest 4Health News:Better cholesterol drugs may follow Saint Louis University researcher's breakthrough 2Health News:USF and Saneron get $2.6 million to develop Alzheimer's treatment using umbilical cord blood cells 2Health News:Shortfalls in carotenoid intake may impact women's health 2Health News:Shortfalls in carotenoid intake may impact women's health 3Health News:Shortfalls in carotenoid intake may impact women's health 4Health News:Elsevier's BrainNavigator 3.0 reflects the next step in enhancing neurological research 2Health News:Elsevier's BrainNavigator 3.0 reflects the next step in enhancing neurological research 3
(Date:5/21/2015)... May 21, 2015 Thirteen winners of ... designed to bring promising medical inventions to market, ... (HPN) in collaboration with the National Institutes of ... (CAI).  The winning teams were selected based on ... and will move forward to phase three of ...
(Date:5/21/2015)...  AbbVie (NYSE: ABBV ) announced today the ... announced offer to acquire each outstanding share of common ... cash and AbbVie common stock, as described in the ... and Exchange Commission by AbbVie on March 23, 2015, ... offer will expire at 5:00 p.m., New ...
(Date:5/21/2015)... Delcath Systems, Inc. (NASDAQ: DCTH ) ... its expanded Global Phase 2 Clinical Trial Program of ... unresectable hepatocellular carcinoma (primary liver cancer, or HCC) has ... conducted at the same hospitals in Europe ... trial, and ICC enrollment is now open at Goethe ...
Breaking Medicine Technology:Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 2Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 3Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 4AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 2AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 3AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 4ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 2ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 3ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 4
... 18 Aida,Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) ... is developing a potential cancer drug,that seeks to ... a pre-clinical product being developed by Aida,s Shanghai,Qiaer ... the,function of extracted fragments of Vasostatin, an inhibitor ...
... CARLSBAD, Calif., April 18 Isis,Pharmaceuticals, Inc. ... of two studies,designed to assess the impact ... Annual Atherosclerosis, Thrombosis and Vascular Biology (ATVB),Conference ... in a poster,entitled "Antisense Inhibition of Apolipoprotein ...
Cached Medicine Technology:Aida Announces New Anti-Cancer Drug Under Development 2Isis Reports Reduction of apoB-100 Levels in a Murine Model Resulting in Up to 92% Reduction of Atherosclerosis 2Isis Reports Reduction of apoB-100 Levels in a Murine Model Resulting in Up to 92% Reduction of Atherosclerosis 3Isis Reports Reduction of apoB-100 Levels in a Murine Model Resulting in Up to 92% Reduction of Atherosclerosis 4
... IMPACs comprehensive information system designed specifically ... integrate and streamline their diagnostic, management, ... intuitive software solution. Thousands of laboratory ... have proven PowerPaths unique "case-centric model ...
The most compact revolutionary innovation in hematology. 26 paramaters with 5 part DIFF....
... The remote vision controls ... NP-3S chart projector from the ... the autorefraction measurements can be ... via wireless data transfer. The ...
... (threshold) testing provides clinically beneficial information ... conditions. Dark adaptometry is useful in ... degenerations, senile miosis, high myopia, vitamin-A ... while whole-field scotopic sensitivity has been ...
Medicine Products: